Medlive Technology Co., a leading player in the healthcare technology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2015, the company has rapidly established itself as a pioneer in medical data solutions, telemedicine, and healthcare management systems. Medlive's core offerings include advanced medical imaging software and integrated health information platforms, designed to enhance clinical decision-making and improve patient outcomes. What sets Medlive apart is its commitment to innovation, leveraging cutting-edge technology to streamline healthcare processes. With a strong market position, Medlive Technology Co. has achieved significant milestones, including partnerships with major healthcare institutions and recognition for its contributions to digital health. The company continues to drive advancements in the industry, making healthcare more accessible and efficient for providers and patients alike.
How does Medlive Technology Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Medlive Technology Co's score of 8 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Medlive Technology Co, headquartered in CN, reported total carbon emissions of approximately 768,176,000 kg CO2e, with Scope 2 emissions accounting for about 60,102,000 kg CO2e and Scope 1 emissions at zero. This marks a slight increase in Scope 2 emissions from 67,758,000 kg CO2e in 2022 and 67,396,000 kg CO2e in 2021. Despite these figures, Medlive Technology Co has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of defined climate commitments or pledges suggests a need for further action in addressing their overall emissions, particularly in Scope 3, which represents a significant portion of their total emissions. As the company continues to grow, it will be crucial for Medlive Technology Co to establish clear climate strategies to mitigate their environmental impact and align with industry standards for sustainability.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2021 | 2022 | 2023 | |
---|---|---|---|
Scope 1 | - | - | - |
Scope 2 | 67,396,000 | 00,000,000 | 00,000,000 |
Scope 3 | - | - | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medlive Technology Co is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.